tiprankstipranks
Advertisement
Advertisement
BioNTech and Bristol Myers Squibb Report Strong Interim Phase 2 Lung Cancer Data for Bispecific Pumitamig
PremiumCompany AnnouncementsBioNTech and Bristol Myers Squibb Report Strong Interim Phase 2 Lung Cancer Data for Bispecific Pumitamig
2M ago
BioNTech, Bristol announce interim Phase 2 data from Rosetta Lung-02 trial
Premium
The Fly
BioNTech, Bristol announce interim Phase 2 data from Rosetta Lung-02 trial
2M ago
Lamb Weston, FedEx, BioNTech, Zscaler, Larimar Trending With Analysts
Premium
Weekend Updates
Lamb Weston, FedEx, BioNTech, Zscaler, Larimar Trending With Analysts
2M ago
Bernstein starts BioNTech at Market Perform, sees high registration risk
PremiumThe FlyBernstein starts BioNTech at Market Perform, sees high registration risk
2M ago
BioNTech initiated with a Market Perform at Bernstein
Premium
The Fly
BioNTech initiated with a Market Perform at Bernstein
2M ago
BioNTech Shareholders Back All Proposals and Strengthen Supervisory Board at 2026 AGM
Premium
Company Announcements
BioNTech Shareholders Back All Proposals and Strengthen Supervisory Board at 2026 AGM
2M ago
BioNTech announces new $1B ADS repurchase program
PremiumThe FlyBioNTech announces new $1B ADS repurchase program
3M ago
BioNTech Launches $1 Billion ADS Buyback to Support Long-Term Growth Strategy
Premium
Company Announcements
BioNTech Launches $1 Billion ADS Buyback to Support Long-Term Growth Strategy
3M ago
BioNTech price target lowered to $158 from $171 at Canaccord
Premium
The Fly
BioNTech price target lowered to $158 from $171 at Canaccord
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100